Valiant Organics Limited (VALIANTORG) Fair Value & Analysis

Basic Materials · IN · Market cap ₹7.8B

A solid business, but screening 35% overvalued on our models.

What matters now

• The price sits above even our optimistic bull case (₹251.92). The favourable scenario is already priced in.
• Solid but not exceptional quality (56/100) and above fair value, neither a clear bargain nor a standout compounder.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range ₹197.64 – ₹1,772 · fair‑value band ₹160.10 – ₹251.92 · the ₹308.30 price screens above the ₹201.54 fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Valiant Organics Limited (VALIANTORG) currently trades at ₹308.30, while our model-based Fair Value estimate is ₹201.54, implying the stock looks roughly 34.6% overvalued today. The Quality Score stands at 56/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Valiant Organics Limited generated revenue of ₹7.4B at a net margin of 4.5%. Revenue grew 6.9% year over year. It earns a return on equity of 4.5%. Net debt stands at ₹2.5B. Fundamentals as of Aug 13, 2026

Our scenario range runs from ₹160.10 (bear case) to ₹251.92 (bull case); at ₹308.30, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 29% below its 52-week high and 58% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -60% fair-value upside, at -35%, VALIANTORG screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Widest divergence: DCF Models (₹365.37) versus Dividend Discount (₹65.92). Highest evidence: Growth DCF (80).

Key figures & financial health

Quality Score breakdown

About the company

Valiant Organics Limited, a chemical manufacturing company, manufactures and markets specialty chemicals in India and internationally.

Full company description

Valiant Organics Limited, a chemical manufacturing company, manufactures and markets specialty chemicals in India and internationally. The company offers para chloro phenol; ortho chloro phenol; 2,4 di chloro phenol; 2,4,6 tri chloro phenol; n-isopropyl para chloro aniline; meta chloro aniline; para flouro aniline; 4-flouro-N-isopropylaniline; 2,4-dichlorophenoxyacetic acid; para nitro aniline; ortho chloro para nitro aniline; ortho anisidine; para anisidine; ortho toluidine 5 sulfonic acid; 6 acetyl oapsa; ortho nitro aniline para sulphonic acid; ortho amino phenol; 4B and 2B acid; 2,6 di chloro phenol; and para"amino phenol. It also provides IPPCA, OA/PA acetanilide, OT5SA, ortho nitro anisole, and para nitro anisole. The company's products are primarily used as intermediates in agro chemicals, dyes, pigments, pharmaceuticals, cosmetics, specialty chemicals, polymers, and veterinary drugs. It exports its products to Asia, Europe, and the United States. Valiant Organics Limited was incorporated in 1984 and is headquartered in Mumbai, India.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Valiant Organics Limited reported revenue of ₹7.4B in FY2026 versus ₹11.5B in FY2022, a compound −10.5%/yr. Reported net income was ₹332M in FY2026, compounding −26.4%/yr from FY2022.

VALIANTORG screens 35% overvalued. Compare with BASF SE →

Peer Group

Chemicals · 332 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Chemicals median · lower = cheaper

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Explore undervalued stocks

More undervalued Basic Materials stocks →

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.